Symbios Technologies is a world-leading developer of dynamic aqueous plasma technology platforms for biotherapeutic applications, water treatment, and specialty manufacturing. The privately held company was founded in January 2008 and is headquartered in Fort Collins, Colorado at the Colorado State University (CSU) Research Innovation Center within the Infectious Disease Research Center (IDRC) on the CSU Foothills Campus. Initial technology development and vetting was performed at the University of Wisconsin, Colorado State University, and the U.S. Naval Research Laboratory. Currently, the TPR is being advanced by Symbios under Phase II Small Business and Innovation Research (SBIR) grant support from the U.S. National Science Foundation (NSF), National Institute of Health (NIH), joint development agreements, and strategic funding with previous funding including the U.S. Department of Energy (DOE) and other partners.
